Colistimethate sodium is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Qilu Hospital of Shandong University (1) and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1). Registered phases: Not applicable and Phase 2. Conditions studied include Ventilator-Associated Pneumonia (VAP); Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07512596 | Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria (ClinicalTrials.gov ↗) Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia |
Phase 2 | Recruiting |
| NCT06834971 | Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial (ClinicalTrials.gov ↗) Ventilator-Associated Pneumonia (VAP) |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Ventilator-Associated Pneumonia (VAP) | 1 |
| Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia | 1 |
| Lead sponsor | Trials |
|---|---|
| Qilu Hospital of Shandong University | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Register | Colistimethate sodium trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Colistimethate sodium works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Colistimethate sodium (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.